A New Strategy for High-Sensitivity Troponin in the ED A New Strategy for High-Sensitivity Troponin in the ED

Is it time to extend our use of hs-cTn in the acute setting beyond just ruling out acute illness? In this commentary, the author explores the utility of hs-cTn as a marker of subclinical pathology.Journal of the American College of Cardiology

Source: Medscape Today Headlines - December 13, 2017 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news